MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-AP-10-0007329
Cornileus Pharmaceuticals Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹16.06 Cr
▼ 60% YoY
Net profit · FY 2024
₹55.92 Lakh
Net margin 3.5%
EBITDA · FY 2024
₹3.31 Cr
EBITDA margin 20.6%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹4.59 Cr
Issued & subscribed
Open charges
₹17 Cr
Satisfied ₹66.56 Cr
Company age
25 yrs
Est. 2001
Employees · EPFO
124
Provident fund records
About Cornileus Pharmaceuticals Private Limited
Data last updated:
Cornileus Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 28 December 2001 and has been in existence for over 25 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2001PTC038288. Its GSTIN is 36AABCC6487H1ZF (Telangana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.59 Cr. It is led by directors including Kiran Kumar Nalamothu (Managing Director) and Jagarlamudi Suresh Babu.
Its last annual general meeting (AGM) was held on 25 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at H.No:1 – 98/V/103 Flat No.103 Plot No.17&18 Vishnu Avenues Krithika Layout Madhapur, Hyderabad, Telangana, India – 500081.
As per the financials filed for FY 2024, the company reported a revenue of ₹16.06 Cr, a decline of 60% compared to the previous year. For the same year it recorded a net profit of ₹55.92 Lakh (net margin 3.5%) and EBITDA of ₹3.31 Cr (EBITDA margin 20.6%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years and 1% over five years.
The company has about 124 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Cornileus Pharmaceuticals. As per MCA filings, the company has open charges of ₹17 Cr and satisfied charges of ₹66.56 Cr on record. Court records list 12 cases involving the company, including 9 filed by the company and 3 filed against it; 2 cases are pending.
Cornileus Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-AP-10-0007329). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cornileus.com.
Company details
CIN U24239TG2001PTC038288
Registration Number 038288
Incorporation Date 28 December 2001
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 25 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-AP-10-0007329
CIN history
Cornileus Pharmaceuticals has one previous CIN (Corporate Identification Number): U24239AP2001PTC038288. The current CIN is U24239TG2001PTC038288, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2001PTC038288 | Current |
| U24239AP2001PTC038288 | Previous |
Key People
Kiran Kumar Nalamothu Managing Director Jagarlamudi Suresh Babu Director Venkat Samraj Jagarlamudi Director Recognitions & Rankings of Cornileus Pharmaceuticals
Contact details
Cornileus Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its website is cornileus.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressH.No:1 – 98/V/103 Flat No.103 Plot No.17&18 Vishnu Avenues Krithika Layout Madhapur, Hyderabad, Telangana, India – 500081
- IndustryPharma, API Manufacturers
To see the full contact details of Cornileus Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Cornileus Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Cornileus Pharmaceuticals operates one associated brand: Cornileus Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical research, manufacturing, and marketing of pellets and spheres in India with global operations. | cornileus.com |
Business activity
The main business activity of Cornileus Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Cornileus Pharmaceuticals Private Limited, buy the company report.
Financials of Cornileus Pharmaceuticals Private Limited
FY 2024 filings availableCornileus Pharmaceuticals Private Limited reported revenue of ₹16.06 Cr (down 60% YoY) for FY 2024.
Revenue · FY 2024
₹16.06 Cr ▼ 60%
Net profit · FY 2024
₹55.92 Lakh margin 3.5%
EBITDA · FY 2024
₹3.31 Cr margin 20.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 60%
3 years · compounded
▲ 9%
5 years · compounded
▼ 1%
EBITDA CAGR growth
1 year
▼ 69%
3 years · compounded
▲ 20%
5 years · compounded
▲ 4%
Revenue has declined at a compounded annual rate (CAGR) of 1% over five years, including a 60% fall in the latest year. EBITDA fell 69% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.31 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹55.92 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 20.6% | ||||
| Net Profit Margin | 3.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cornileus Pharmaceuticals Private Limited, buy the company report.
Board of directors of Cornileus Pharmaceuticals Private Limited
Cornileus Pharmaceuticals has 4 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jagarlamudi Suresh Babu | Director | 28 Dec 2020 | 5 Years 10 Months | Current |
| Kiran Kumar Nalamothu Also directs: Regius Pharma LLP | Managing Director | 05 Nov 2018 | 7 Years 11 Months | Current |
| Venkat Samraj Jagarlamudi Also directs: Sakar Dairy LLP | Director | 28 Dec 2020 | 5 Years 10 Months | Current |
| Vijayalakshmi Nalamothu Also directs: Regius Pharma LLP | Director | 17 Oct 2017 | 9 Years 0 Months | Current |
Peer comparison
Cornileus Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (API Manufacturers, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| M.N.Chemicals Limited | ₹16.13 Cr (FY 2025) | 23.0% | Bangalore, Karnataka, India | |||
| Polo Pharmaceuticals Private Limited | ₹16.12 Cr (FY 2025) | 18.0% | Himachal Pradesh, India | |||
| Vetfar Pharmaceuticals Private Limited | ₹16.11 Cr (FY 2025) | 532.0% | Mumbai, Maharashtra, India | |||
| Palam Pharma Private Limited | ₹16.11 Cr (FY 2025) | 9.0% | Ahmedabad, Gujarat, India | |||
| Cornileus Pharmaceuticals Private Limitedthis company | ₹16.06 Cr (FY 2024) | ₹55.92 Lakh | 3.5% | -60.0% | 124 | Hyderabad, Telangana, India |
| Addom Pharmaceuticals Private Limited | ₹16.02 Cr (FY 2024) | 2630.0% | Patna, Bihar, India | |||
| Suma Pharmaceuticals Private Limited | ₹15.75 Cr (FY 2024) | 9.0% | Ambernath, Maharashtra, India |
To see the full peer comparison of Cornileus Pharmaceuticals Private Limited, buy the company report.
Auditor
Cornileus Pharmaceuticals Private Limited is audited by R.B.ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R.B.ASSOCIATES | FY 2023 | 009112S |
Shareholding
The shareholding of Cornileus Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Cornileus Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹17 Cr
Satisfied charges
₹66.56 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 May 2024 | 100924158 | Others | ₹7.5 Cr | Open | |
| 01 Feb 2019 | 100238506 | Others | ₹9.5 Cr | Open | |
| 07 Feb 2020 | 100326337 | State Bank of India | ₹31.71 Cr | Satisfied | |
| 25 Sep 2013 | 10454812 | Andhra Bank | ₹1 Cr | Satisfied | |
| 23 Aug 2011 | 10310140 | Andhra Bank | ₹3 Cr | Satisfied |
To see the full charge records of Cornileus Pharmaceuticals Private Limited, buy the company report.
Total charge records: 9 View all charges
Legal cases
Cornileus Pharmaceuticals Private Limited has 12 court cases on record: 9 filed by Cornileus Pharmaceuticals, 3 filed against it. 2 cases are pending and 10 are disposed.
Total cases
12
Filed by the company
9
Filed against the company
3
Pending
2
Disposed
10
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 6 | 2 | 2 |
| High courts | 4 | 1 | 0 |
| NCLT | 2 | 0 | 0 |
Cases on record (5 of 12)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Rangareddy, Telangana | Civil suit | Filed by the company against M/S.Concord Drugs Ltd. | Pending |
| NCLT, Hyderabad | Court case (C.A.(CAA)) | Filed by the company against Regius Pharma Private Limited | Disposed |
| District court, Rangareddy, Telangana | Civil suit | Filed by the company against M/S.Concord Drugs Ltd. | Disposed |
| NCLT, Hyderabad | Court case (C.P.(CAA)) | Filed by the company against Regius Pharma Private Limited | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Civil suit | Filed against the company by Ms.Nova Oleochem Ltd Th.Ms.Mamta Varma | Disposed |
To see the full case history of Cornileus Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cornileus Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Cornileus Pharmaceuticals Private Limited has a workforce of 124 employees on its EPFO records as of Mar 29, 2024, across 2 active EPFO establishments.
Employee count
124
Active EPFO establishments
2
Employee growth
6.9%
GST
Cornileus Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCC6487H1ZF | Telangana | Active | 01 Jul 2017 |
| 37AABCC6487H1ZD | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Cornileus Pharmaceuticals Private Limited, buy the company report.
Recent activity
Cornileus Pharmaceuticals Private Limited has 13 board changes on record since 2011: 4 appointments and 9 cessations. The latest: Jagarlamudi Suresh Babu ceased to be Additional Director on 25 Oct 2021.
Charges
A charge registered on 07 Feb 2020 via Charge ID 100326337 with State Bank Of India was fully satisfied on 20 Jun 2025.
AGM
Cornileus Pharmaceuticals Private Limited last Annual general meeting of members was held on 25 Sep 2024 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 7.50 Cr with Charge ID 100924158 was registered on 06 May 2024.
Filing
Cornileus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge with Others of Rs. 9.50 Cr registered on 01 Feb 2019 with Charge ID 100238506 was modified on 20 Sep 2022.
Ceased
Jagarlamudi Suresh Babu ceased to be Additional Director.
Ceased
Venkat Samraj Jagarlamudi ceased to be Additional Director.
Appointed
Jagarlamudi Suresh Babu was appointed as Director.
Ceased
Sampath Kumar Kandukuri ceased to be Director.
Appointed
Venkat Samraj Jagarlamudi was appointed as Director.
Charges
A charge with State Bank Of India of Rs. 31.71 Cr registered on 07 Feb 2020 with Charge ID 100326337 was modified on 12 Aug 2020.
Charges
A charge with State Bank Of India amounted to Rs. 31.71 Cr with Charge ID 100326337 was registered on 07 Feb 2020.
25 earlier events are in the company report.
Frequently asked questions
Cornileus Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 28 December 2001 (25+ years old) and is registered under CIN U24239TG2001PTC038288.
Cornileus Pharmaceuticals has 4 current directors:
- Kiran Kumar Nalamothu - Managing Director
- Jagarlamudi Suresh Babu - Director
- Venkat Samraj Jagarlamudi - Director
- Vijayalakshmi Nalamothu - Director
The latest financial statements of Cornileus Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 25 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Cornileus Pharmaceuticals is 36AABCC6487H1ZF, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AABCC6487H1ZD (Andhra Pradesh).
The CIN (Corporate Identification Number) of Cornileus Pharmaceuticals is U24239TG2001PTC038288. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cornileus Pharmaceuticals has 12 court cases on record: 9 filed by the company and 3 filed against it. 2 are pending. Most are in the district courts.
Cornileus Pharmaceuticals was incorporated on 28 December 2001, making it 25+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Cornileus Pharmaceuticals by revenue are M.N.Chemicals Limited, Polo Pharmaceuticals Private Limited, Vetfar Pharmaceuticals Private Limited, Palam Pharma Private Limited, Addom Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (API Manufacturers, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Jagarlamudi Suresh Babu ceased to be Additional Director on 25 Oct 2021. Venkat Samraj Jagarlamudi ceased to be Additional Director on 25 Oct 2021. Jagarlamudi Suresh Babu was appointed as Director on 28 Dec 2020. Cornileus Pharmaceuticals has 13 board changes on record in total.
Yes, Cornileus Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-AP-10-0007329).
Cornileus Pharmaceuticals can be reached through the website cornileus.com. Its registered office is in Hyderabad, Telangana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages